The Poison That Heals. Botox, a lethal neurotoxin that doubles as a miracle cure, is a medical paradox. This two-part series dives into the history, science, and dark side of Botox. Part 1covers its rise as a medical marvel, while Part 2 states discuss the growing risks of the unlicensed “Black Market”
Part: 2
History of Overdose
Historically, the most severe cases have been linked to off-label therapeutic use, particularly in children requiring high doses for conditions like cerebral palsy. In 2009, the FDA mandated a “Black Box” warning, cautioning that the toxin’s effects could spread beyond the injection site.⁷
In 2012, a New York family won a multi-million-dollar verdict after their young son developed life-threatening complications from high-dose, off-label injections.⁸ The dose exceeded recommended limits and was not FDA-approved for pediatric use. This caused systemic spread, leading to facial swelling, respiratory compromise, and debilitating epileptic seizures.
The Rise of Counterfeits
Today, the greatest threat comes from counterfeit products sold to unlicensed providers.
- Early Warnings: In 2012 and 2013, the FDA sent over 600 warning letters to practices purchasing unapproved toxins from foreign or online suppliers.⁹,¹⁰
- The Egypt Outbreak: In 2017, Egypt witnessed an outbreak of iatrogenic botulism in nine patients. The cause was a counterfeit, highly concentrated preparation sold as Neuroxin®.¹¹ Patients suffered from widespread muscle weakness, difficulty swallowing, and bilateral ptosis (drooping eyelids).
- The 2024 Crisis: The CDC and FDA recently investigated 22 cases across 11 U.S. states linked to counterfeit products. 91% of these individuals received injections from unlicensed individuals in non-healthcare settings like homes or spas.¹² Eleven were hospitalized, and six required antitoxin treatment.
Current Regulation
In November 2025, the FDA ramped up enforcement by issuing 18 warning letters to website operators illegally marketing unapproved toxins.¹³ FDA Commissioner Marty Makary, MD, MPH, stated that these actions are vital to protect consumers from “dangerous products.”
Ultimately, the safety of botulinum toxin relies entirely on authentic, FDA-approved products administered by trained medical professionals. While the promise of “young” skin is attractive, one cannot be careful enough when dealing with a life-threatening toxin.
Further reads
- Kuehn BM. FDA requires black box warnings on labeling for botulinum toxin products. JAMA. 2009;301(22):2316.
- AP News, By Dave Grama associated Press Published 4:56 PM CST, November 20, 2014.
- https://www.fda.gov/media/100129/download
- https://www.fda.gov/media/128564/download?attachment
- Rashid EAMA, El-Mahdy NM, Kharoub HS, Gouda AS, ElNabarawy NA, Mégarbane B. Iatrogenic Botulism Outbreak in Egypt due to a Counterfeit Botulinum Toxin A Preparation – A Descriptive Series of Patient Features and Outcome. Basic Clin Pharmacol Toxicol. 2018;123(5):622-627.6
- https://www.cdc.gov/botulism/outbreaks/harmful-reactions-botox-injections/details.html
- https://www.fda.gov/news-events/press-announcements/fda-warns-companies-over-illegal-marketing-botox-and-related-products
Disclaimer
The editors take care to share authentic information. In case of any discrepancies please write to newsletter@medness.org.
The sponsors do not have any influence on the nature or kind of the news/analysis reported in MedNess. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of MedNess. Examples of analysis performed within this article are only examples. They should not be utilized in real-world analytic products as they are based only on very limited and dated open-source information. Assumptions made within the analysis are not reflective of the position of anyone volunteering or working for MedNess. This blog is strictly for news and information. It does not provide medical advice, diagnosis or treatment nor investment suggestions. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
MedNess is a part of STEMPeers® which is a 501(c)(3) organization registered in PA as PhD Career Support Group. The organization helps create a growing network of STEM scientists that is involved in peer-to-peer mentoring and support.
